BMD4702

  Cat. No.:  DC74449  
Chemical Structure
335206-54-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
BMD4702 is a small molecule Dishevelled (Dvl) PDZ domain with binding Kd of 186 nM.
Cas No.: 335206-54-7
Chemical Name: BMD4702
SMILES: O=C(O)COC1=C(OCC)C=C(/C=C2C(C3=CC=CC=C3S/2)=O)C=C1Br
Formula: C19H15BrO5S
M.Wt: 435.29
MSDS
Cat. No. Product name Field of application
DC74451 NPL-4011 NPL-4011 is a specific small molecule inhibitor of PDZ domain of human Dvl1 (Dvl1-PDZ) with KD vaule of 34.5 uM in NMR titration experiments.
DC74450 BMD4722 BMD4722 is a highly potent, small-molecule inhibitor of Dvl-CXXC5 interaction with IC50 of 2.59 uM, directly binds to the Dvl PDZ domain (Kd=22.3 uM).
DC74449 BMD4702 BMD4702 is a small molecule Dishevelled (Dvl) PDZ domain with binding Kd of 186 nM.
DC70553 KY19334 KY19334 is a specific small molecule inhibitor of CXXC5-Dishevelled (Dvl) protein-protein interaction (PPI), restores the Wnt/β‐catenin signalling.KY19334 reverses obesity‐related metabolic diseases with adult tissue remodelling.Oral administration of KY19334 (25 mg/kg) suppressed fasting glucose levels improves obesity‐related insulin resistance with long‐lasting effect in HFD‐fed mice.KY19334 treatment improves hepatic glucose homeostasis. KY19334 enhances energy expenditure by increasing the thermogenic activity of beige‐fat tissues.KY19334 treatment restores β‐cell mass and functions in HFD‐fed and STZ‐induced diabetes mellitus (DM) mice.
X